Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -1.119\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) Cc1ccc(CNC(=O)C2CCC(=O)N(Cc3ccccc3F)C2)s1
b) FC(F)(F)c1ccc(Sc2nnc(-c3cccs3)n2CC2CCCO2)nc1
c) CN(CC1COc2ccccc2O1)C(=O)CSc1ncnc2sccc12
d) CSc1ccc(CN2CCN(C(=O)COc3cccc(C)c3)CC2)cc1
Answer: c. CN(CC1COc2ccccc2O1)C(=O)CSc1ncnc2sccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(CC1COc2ccccc2O1)C(=O)CSc1ncnc2sccc12
CN(CC1COc2ccccc2O1)C(=O)CSc1ncnc2sccc12
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-N-methyl-2-thieno[2,3-d]pyrimidin-4-ylsulfanylacetamide